Growth Metrics

Cabaletta Bio (CABA) Non-Current Assets (2018 - 2025)

Cabaletta Bio's quarterly Non-Current Assets came in at $26.2 million in Q4 2025, up 42.68% year-on-year from $18.4 million in Q4 2024, and up 4.02% quarter-over-quarter from $25.2 million in Q3 2025.

Cabaletta Bio has reported Non-Current Assets for 8 years, with the latest figure at $26.2 million in Q4 2025.

  • For the quarter ending Q4 2025, Non-Current Assets rose 42.68% year-over-year to $26.2 million; the trailing twelve-month figure through Dec 2025 stood at $108.0 million (up 75.96% YoY), and the FY2025 full-year result was $26.2 million, up 42.68% from the prior year.
  • Non-Current Assets for Q4 2025 stood at $26.2 million, up from $25.2 million in the prior quarter.
  • The five-year high for Non-Current Assets was $30.5 million in Q1 2025, with the low at $1.5 million in Q1 2021.
  • Average Non-Current Assets over 5 years is $11.2 million, with a median of $7.9 million recorded in 2022.
  • Year-over-year, Non-Current Assets plunged 56.74% in 2021 and surged 353.15% in 2022.
  • Tracing CABA's Non-Current Assets over 5 years: stood at $1.8 million in 2021, then surged by 353.15% to $8.1 million in 2022, then gained by 12.61% to $9.2 million in 2023, then surged by 100.56% to $18.4 million in 2024, then surged by 42.68% to $26.2 million in 2025.
  • The last three Non-Current Assets figures came in at $26.2 million (Q4 2025), $25.2 million (Q3 2025), and $26.1 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 4.56 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - 62,953.78
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 486.60 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - 5.83 Mn
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 30.30 Mn
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 14.75 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 22.66 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 910.24 Mn
10 Cabaletta Bio 194.84 Mn 61.24 Mn - 26.21 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 26.21 Mn
Sep 30, 2025 25.20 Mn
Jun 30, 2025 26.09 Mn
Mar 31, 2025 30.55 Mn
Dec 31, 2024 18.37 Mn
Sep 30, 2024 18.90 Mn
Jun 30, 2024 11.16 Mn
Mar 31, 2024 12.98 Mn
Dec 31, 2023 9.16 Mn
Sep 30, 2023 7.11 Mn
Jun 30, 2023 7.07 Mn
Mar 31, 2023 7.71 Mn
Dec 31, 2022 8.13 Mn
Sep 30, 2022 3.50 Mn
Jun 30, 2022 3.27 Mn
Mar 31, 2022 2.22 Mn
Dec 31, 2021 1.80 Mn
Sep 30, 2021 1.79 Mn
Jun 30, 2021 1.92 Mn
Mar 31, 2021 1.53 Mn
Dec 31, 2020 1.19 Mn
Sep 30, 2020 2.55 Mn
Jun 30, 2020 4.43 Mn
Mar 31, 2020 843,000.00
Dec 31, 2019 916,000.00
Sep 30, 2019 3.19 Mn
Dec 31, 2018 180,000.00